Senior insider sale
SVP, Global Regulatory Affairs at REATA PHARMACEUTICALS INC — senior position signals high conviction
$546.2K
3.17K shares
LOEWEN ANDREA plans to sell 3.17K shares of REATA PHARMACEUTICALS INC valued at approximately $546.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 172.00 | — |
5/12/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 147.00 | — |
3/6/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.23K | — |
3/4/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 250.00 | — |
3/2/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 373.00 | — |
| Total | 3.17K | ||
Units to sell
3.17K
Market value
$546.2K
Units
3.17K
Value
$546.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/14/2023 | 3.17K | $546.2K | NASDAQ | Planned |
| Total | 3.17K | $546.2K | ||